Abstract
In the era of the COVID-19 pandemic, unprecedented efforts have been made by governments and the scientific community to develop vaccines. Vaccines developed on the basis of new technologies have proven to be effective and safe. The accumulated experience in vaccine development on the basis of human adenovirus DNA has allowed domestic scientists to develop and launch the worlds first vaccine against a new coronavirus infection, Sputnik V, in a short period of time, which has received worldwide recognition. Pre-registration trials may be insufficient to detect rare post-vaccination complications, and the lack of information about them may cause distrust in vaccination companies among part of the population. A review of the worldwide literature on SARS-CoV-2 vaccine-related complications is presented. It concludes that vaccination is superior to their risks. An oculomotor nerve injury following vaccination with Sputnik Lite in a 67-year-old woman with a favourable outcome is described.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
